Nivalis Therapeutics Inc.

July 8, 2016July 8, 2016

Nivalis Completes Enrollment in Phase 2 Study of Cystic Fibrosis Therapy

Cystic Fibrosis, News

Nivalis Therapeutics has enrolled the last patient in the larger of two Phase 2 clinical trials evaluating the company’s lead clinical candidate, N91115, for the treatment of cystic fibrosis patients with two faulty copies ... Read more

May 24, 2016May 24, 2016

First Patient Dosed in Phase 2 Trial of Potential CF Treatment

Cystic Fibrosis, News

Nivalis Therapeutics, Inc., announced the first dosing of a cystic fibrosis (CF) patient enrolled in its second Phase 2 clinical trial evaluating the drug N91115, a stabilizer of the cystic fibrosis transmembrane conductance regulator ... Read more